The CBD sector has grown at an impressive clip in recent years and if you are looking for CBD stocks at this point, then it could be a good idea to take a closer look at the CBD Life Sciences (OTCMKTS:CBDL) stock.
Yesterday, the CBD Life Sciences stock was in considerable focus among investors and went up by as much as 25% amidst heavy interest. While that may be true, it is also true that there was no specific news about the company that might have led to such gains. However, last month, the company announced that it was in the process of expand its product line again by introducing a new pain relief cream through its fully owned subsidiary company LBC Bioscience Inc.
It was revealed at the time that the company working with a 3000 MG pain relief cream that was much stronger than the existing 1200 MG pain relief cream.
Lisa Nelson, who is the Chief Executive Officer and President of the company, noted that it is a product that could provide instance relief and it is something that could be particularly helpful for athletes. While there is no recent news, investors could consider keeping an eye on this stock at this point.
Market Reaction:
On Wednesday, CBDL stock rose 25% at $0.0005 with more than 1.22 billion shares, compared to its average volume of 472.55 million shares. The stock had moved within a range of $0.0004 – 0.0006 after opening the trade at $0.0004. Over the past 52-week, the stock has been trading within a range of $0.0004 – 0.0198.
 Stock Surges 25%: What to Expect Now?){kind=link}